Viewing Study NCT06823856

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-04-09 @ 12:40 AM
Study NCT ID: NCT06823856
Status: COMPLETED
Last Update Posted: 2025-05-23
First Post: 2025-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)
Sponsor: Gedeon Richter Plc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes View
None Diabetes Mellitus Type 2 View
None Empagliflozin View
None Metformin View